Video

ASCO President Dr Peter Yu Discusses Aggregating Patient, Doctor Data

The move toward an age of digital health will allow doctors to learn more and faster when it comes to drug toxicity and side effects, according to Peter P. Yu, MD, FASCO, 2014-2015 ASCO president.

The move toward an age of digital health will allow doctors to learn more and faster when it comes to drug toxicity and side effects, according to Peter P. Yu, MD, FASCO, 2014-2015 ASCO president and director of cancer research at the Palo Alto Medical Foundation.

Dr Yu will serve as a keynote speaker for The American Journal of Managed Care's 3rd annual "Patient-Centered Oncology Care" meeting on November 13-14 in Baltimore, MD

He outlined the use of ASCO’s health IT platform, CancerLinQ, which will collect data across hundreds of providers and thousands of patients and avoid the bias that can be present in small sample sizes.

“CancerLinQ will allow us to amass this data, aggregate it and analyze it, and then learn from that,” Dr Yu explained. “If that is then married to clinical decision support, so that information is returned to the doctor at the point of care, it will allow the physician to more rapidly consider choices and make better treatment decisions.”

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Surbhi Sidana, MD, MBBS, Stanford University
Gordon Crofoot, MD, PA
David Awad, PharmD, BCOP
Merrill H. Stewart, MD
Saad Z. Usmani, MD, MBA, FACP, FASCO, Memorial Sloan Kettering Cancer Center
Andrew Evens, DO, MBA, MSc, deputy director for clinical services and chief physician officer, Rutgers Cancer Institute and Jack & Sheryl Morris Cancer Center
Hamlet Gasoyan, PhD
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo